Literature DB >> 20089981

Interleukin-2 therapy in patients with HIV infection.

Pierre Sellier, Carmelo Lafuente-Lafuente, Jean-François Bergmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20089981     DOI： 10.1056/NEJMc0910951

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Blood T-cell receptor diversity decreases during the course of HIV infection, but the potential for a diverse repertoire persists.

Authors:  Paul D Baum; Jennifer J Young; Diane Schmidt; Qianjun Zhang; Rebecca Hoh; Michael Busch; Jeffrey Martin; Steven Deeks; Joseph M McCune
Journal:  Blood       Date:  2012-02-27       Impact factor: 22.113

Review 2.  Soluble mediators of inflammation in HIV and their implications for therapeutics and vaccine development.

Authors:  Sheila M Keating; Evan S Jacobs; Philip J Norris
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-27       Impact factor: 7.638

3.  Deficient IL-2 Produced by Activated CD56+ T Cells Contributes to Impaired NK Cell-Mediated ADCC Function in Chronic HIV-1 Infection.

Authors:  Zhe Xie; Jiajia Zheng; Yuya Wang; Dan Li; Tuohutaerbieke Maermaer; Yuantao Li; Jing Tu; Qiang Xu; Hua Liang; Weiping Cai; Tao Shen
Journal:  Front Immunol       Date:  2019-07-16       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.